Boston Consulting Group's study finds that India is emerging as a leader in AI investment, with 80% of companies prioritising ...
A Black woman is suing the Boston Consulting Group, alleging she was wrongfully fired from her job as a topic expert at the ...
(UroToday.com) The 2024 GU ASCO annual meeting featured a session on the shortage of drugs for urothelial carcinoma and a presentation by Dr. Josh Meeks discussing what is on the horizon to replace ...
TORONTO, ON / ACCESS Newswire / / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and ...
“Patients with BCG-naïve high-risk non-muscle invasive ... Results will be submitted for presentation at an upcoming medical congress. Pfizer plans to discuss these data with global health ...
Sasanlimab (PF-06801591) added to BCG therapy significantly improved outcomes for patients with BCG-naive, high-risk ...
Pfizer’s sasanlimab in combo with BCG improves EFS in patients with BCG-naïve, high-risk non-muscle invasive bladder cancer: New York Monday, January 13, 2025, 13:00 Hrs [IST] ...